(EMAILWIRE.COM, April 24, 2019 ) Rising aging population, increasing incidences of lifestyle diseases, gradual demand for efficient and safe medication with no side effects, and treatment of diseases having a limited success rate are driving the growth of the global market. The market is an emerging market with abundant opportunities and is expected to flourish within five to seven years owing to a number of products currently under the clinical trial phase. In this report, the global market is divided into three major segments namely, application, disease, and product.

The products segment is further classified into: probiotics, prebiotics, food, medical foods, devices, drugs and other probiotic supplements. The probiotics segment is expected to account for the largest share in the market. The large share of this segment can be attributed to the growing adoption of probiotic products.

The disease segment is also further categorized into: obesity, diabetes, autoimmune disorder, cancer, acute diarrhea, mental disorder and other diseases (cardiovascular, metabolic syndrome (elevated blood lipids, high bp, and liver diseases), drug metabolism, and atopic dermatitis).

Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=37621904

Acute diarrhea is expected to account for the largest share of the market. Factors such as rising prevalence of communicable diseases, growing awareness among patients regarding the use of microbiome-based products, and technological advancements will stimulate the growth of this segment in the human microbiome disease market.

The factors restraining the market include lack of comprehensive research to assist in market pull, lack of awareness among the population regarding the efficient usage and effect of prebiotics and probiotics, and impending government regulations on probiotics and prebiotics.

Europe is expected to account for the largest share of the global human microbiome market in 2022. The large share of this region can be attributed to its significant presence in the probiotics and prebiotics fields and the acceptance of these products by its population.

A number of factors such as the rising incidence of cardiovascular disease, increasing awareness about the need for diagnostic and preventive care, and technological advancement are driving the growth of this market. In developed regions like North America, the human microbiome market, in terms of value, is expected to be smaller as compared to Europe, owing to the slower acceptance of microbiome products in a number of countries in this region.

The key players in the human microbiome market are Enterome Bioscience (France), Yakult (Japan), DuPont (U.S.), Metabiomics Corporation (U.S.), ViThera Pharmaceuticals (U.S.), Second Genome Inc. (U.S.), MicroBiome Therapeutics LLC (U.S.), Vedanta BioSciences (U.S.), Osel (U.S.), and Merck (U.S.).

Get the Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=37621904

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com